MPI NEWS
News
You may have noticed that cannabidiol (CBD) seems to be available almost everywhere, and marketed as a variety of products including drugs, food, dietary supplements, cosmetics, and animal health products. Other than one prescription drug product to treat two rare, severe forms of epilepsy, the U.S. Food and Drug Administration (FDA) has not approved any other CBD products, and there is very limited available information about CBD, including about its effects on the body.
This cross-sectional study found that parental recent and past marijuana use was associated with an increased risk of marijuana and other substance use by adolescent and young adult offspring living in the same household. As any substance use among young people increases the probability of using other or multiple psychoactive substances and of experiencing substance-related consequences,preventing a cycle of multigenerational substance use should be a national priority.
About 170 years after California's gold rush came the promise of the green rush.
California's legalization of cannabis for adult recreational use was expected to be massive. In 2016, industry investors claimed sales could top $6.5 billion by 2020.
And as 2019 comes to a close, California is indeed home to the world's largest cannabis market, totaling close to $12 billion in estimated sales. But here's the rub: $8.7 billion of that is changing hands in the illicit market.
Our CCR team is very proud of Joe Eberstein, Program Manager for the County Marijuana Prevention Initiative (MPI), for receiving the Excellence in Prevention Advocacy Award at the Drug Enforcement Administration Red Ribbon Luncheon. Thank you for your dedication and leadership to building healthy and safe communities throughout San Diego County.
The authors of the research published in the journal JAMA Psychiatry argued that while the policies have provided "important social benefits, particularly around issues of equity in criminal justice," the climb in conditions like cannabis use disorder are "a potential public health concern."
To uncover the effects of the changes, researchers looked at surveys completed by 505,796 people between 2008 to 2016. Of the total participants who filled in The National Survey on Drug Use and Health in those years, just over half were female, 77 percent were aged 26 or above, 65 percent were white, 11.9 percent were black, 15.36 percent Hispanic, and 7.3 of another race or ethnicity.